Clinical Trials Browser

Phase 2 × Maraviroc × Sarcoma × Clear all

NCT01276236 2021-03-05

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

Phase 2 Completed

13 enrolled 16 charts

Sarcoma, Kaposi